FDA Approves OZEMPIC — Novo Nordisk Pharmaceutical Industries, LP
# FDA Approves Novo Nordisk's Ozempic for Type 2 Diabetes Treatment Novo Nordisk Pharmaceutical Industries, LP received FDA approval for Ozempic (semaglutide), a once-weekly subcu…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Novo Nordisk's Ozempic for Type 2 Diabetes Treatment Novo Nordisk Pharmaceutical Industries, LP received FDA approval for Ozempic (semaglutide), a once-weekly subcu…
Zhejiang Hisun Pharm has received FDA approval for the generic version of S Combipres (ncludpril & clonidine) indicated for hypertension, securing a significant competitive foothol…
AstraZeneca announced on November 14, 2017, that the FDA granted full approval for its blockbuster respiratory drug FASENRA, the subcutaneous formulation of benralizumab. This appr…
Zhejiang Hisun Pharmaceutical has received FDA approval for its ANDA 204077, a pivotal move that sets the stage for commercial entry into the U.S. market with significant potential…
# FDA Approves AstraZeneca's CALQUENCE (acalabrutinib) for Blood Cancer Treatment AstraZeneca Pharmaceuticals LP received FDA approval for CALQUENCE (acalabrutinib), an oral Bruto…
Eywa Pharma Inc secured FDA approval for its ANDA 210211 covering Hydrocodone Bitartrate and Acetaminophen oral tablets, thereby granting the company a license to manufacture a gen…
1. **Analyze the Request:** * **Topic:** FDA drug approval (generic hydromorphone hydrochloride). * **Key Data:** * Brand/Substance: Hydromorphone Hydrochlor…
On September 25, 2017, Lannett Company received FDA approval for a generic drug indicated by ANDA207333, positioning the company for potential market capture despite unspecified su…
# FDA Approves Actelion Pharmaceuticals' TRACLEER (bosentan) Oral Formulation Actelion Pharmaceuticals US, Inc. received FDA approval for TRACLEER (bosentan) oral formulation unde…
Zydus Pharmaceuticals has received approval from the Food and Drug Administration (FDA) for ANDA 204473, marking a strategic entry into the market that is expected to impact the co…
ANI PHARMS announced August 30, 2017, approval of ANDA 203447 for a generic substance, potentially challenging the current market supply as the company prepares to introduce the th…
PHARM ASSOC announced an FDA approval for ANDA206822 on August 15, 2017, signaling progress in the company's product pipeline; this regulatory clearance is expected to bolster the …
# FDA Approves Zydus Pharmaceuticals' Generic Diltiazem Hydrochloride Zydus Pharmaceuticals (USA) Inc. received FDA approval for its generic diltiazem hydrochloride oral formulati…
Hikma announced FDA approval for its ANDA 208795, a regulatory milestone expected to bolster the company’s commercial pipeline and drive future revenue growth.
On July 21, 2017, the FDA approved OxyCODONE HYDROCHLORIDE tablets under ANDA No. 208593, granting manufacturer KVK-Tech, Inc. immediate access to the U.S. opioid market which is e…
Janssen Biotech announced today that the FDA has approved GUSELKUMAB (TREMFYA), a subcutaneous anti-IL-23r antibody, following a standard six-week review rather than the initial pr…
Accord Healthcare, Inc. received approval of its ANDA for EPLERENONE, strengthening the company's portfolio of oral antihypertensive products. This new line of generics could expan…
# FDA Approves Generic Drug Application for Hikma Pharmaceuticals Hikma Pharmaceuticals received FDA approval for ANDA 208809 on July 6, 2017, expanding its generic drug portfolio…
Amneal Pharmaceuticals announced FDA approval of its Abbreviated New Drug Application number ANDA206869 on June 23, 2017, subjecting the drug to significant pricing pressures. This…
# FDA Approves Generic Drug Application for Actavis Labs FL Inc Actavis Labs FL Inc received FDA approval for ANDA207139 on June 20, 2017, positioning the company to capture marke…